An exploratory clinical trial of apatinib combined with intensity‐modulated radiation therapy for patients with unresectable hepatocellular carcinoma

PURPOSE: To evaluate the clinical efficacy and safety of apatinib combined with intensity‐modulated radiation therapy (IMRT) in patients with unresectable hepatocellular carcinoma (uHCC). MATERIALS AND METHODS: Open‐label, single‐arm, exploratory clinical trial of apatinib combined with IMRT for uHC...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Hu, Ke, Shaobo, Cai, Gaoke, Wu, Yong, Wang, Jin, Shi, Wei, Chen, Jiamei, Peng, Jin, Yu, Baoping, Chen, Yongshun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844642/
https://www.ncbi.nlm.nih.gov/pubmed/35633045
http://dx.doi.org/10.1002/cam4.4900

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844642/
https://www.ncbi.nlm.nih.gov/pubmed/35633045
http://dx.doi.org/10.1002/cam4.4900

Ejemplares similares